Lilly Takes Incretins Beyond Metabolic Diseases Amid Broader Development Push

 
• By Alaric DeArment
  
(Alaric DeArment)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business